Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.89 USD | +2.00% | -8.18% | -31.57% |
Dec. 03 | JPMorgan Adjusts Surgery Partners Price Target to $28 From $38, Maintains Neutral Rating | MT |
Nov. 20 | RBC Cuts Price Target on Surgery Partners to $35 From $49, Keeps Outperform Rating | MT |
Capitalization | 2.77B 2.62B 2.43B 2.17B 3.91B 234B 4.33B 30.2B 11.16B 96.26B 10.39B 10.16B 415B | P/E ratio 2024 * |
-92.8x | P/E ratio 2025 * | 30.8x |
---|---|---|---|---|---|
Enterprise value | 5.79B 5.48B 5.08B 4.55B 8.19B 491B 9.07B 63.25B 23.38B 202B 21.77B 21.28B 869B | EV / Sales 2024 * |
1.88x | EV / Sales 2025 * | 1.72x |
Free-Float |
59.59% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Surgery Partners, Inc.
1 day | +2.00% | ||
1 week | -8.18% | ||
Current month | -8.18% | ||
1 month | -27.90% | ||
3 months | -27.47% | ||
6 months | -14.02% | ||
Current year | -31.57% |
Director | Title | Age | Since |
---|---|---|---|
J. Evans
CEO | Chief Executive Officer | 47 | 2020-01-12 |
David Doherty
DFI | Director of Finance/CFO | 51 | 2022-01-31 |
Varun Gadhok
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
Manager | Title | Age | Since |
---|---|---|---|
William Turner
BRD | Director/Board Member | 58 | 2015-12-29 |
Teresa Deluca
BRD | Director/Board Member | 59 | 2016-09-29 |
T. O'Reilly
CHM | Chairman | 49 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.25% | 5 M€ | -1.80% | - | |
0.20% | 12 M€ | -.--% | - | |
0.08% | 490 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+2.00% | -8.18% | -31.55% | -57.59% | 2.77B | ||
+2.36% | +0.54% | -9.56% | -42.21% | 18.88B | ||
-0.14% | +0.83% | +24.91% | +11.76% | 14.59B | ||
-0.53% | +1.74% | +29.59% | +37.38% | 12.28B | ||
-0.97% | +0.99% | -0.97% | +12.33% | 11.91B | ||
-0.36% | -0.43% | +58.18% | +64.42% | 10.33B | ||
+0.49% | -1.35% | +35.17% | +79.64% | 8.21B | ||
+1.12% | +7.02% | +87.67% | +162.07% | 6.37B | ||
-1.99% | -1.35% | -20.04% | -43.67% | 5.9B | ||
-0.54% | +2.22% | -20.00% | +11.52% | 4.92B | ||
Average | +0.18% | +1.03% | +15.34% | +23.57% | 9.61B | |
Weighted average by Cap. | +0.26% | +1.42% | +17.46% | +20.51% |
2024 * | 2025 * | |
---|---|---|
Net sales | 3.08B 2.91B 2.7B 2.41B 4.35B 261B 4.82B 33.6B 12.42B 107B 11.56B 11.31B 461B | 3.38B 3.2B 2.97B 2.65B 4.78B 287B 5.3B 36.93B 13.65B 118B 12.71B 12.43B 507B |
Net income | -29.5M -27.92M -25.88M -23.14M -41.71M -2.5B -46.17M -322M -119M -1.03B -111M -108M -4.42B | 102M 96.42M 89.38M 79.94M 144M 8.63B 159M 1.11B 411M 3.55B 383M 374M 15.28B |
Net Debt | 3.03B 2.87B 2.66B 2.38B 4.28B 256B 4.74B 33.05B 12.22B 105B 11.37B 11.12B 454B | 3.06B 2.9B 2.69B 2.4B 4.33B 259B 4.79B 33.44B 12.36B 107B 11.51B 11.25B 459B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-06 | 21.89 $ | +2.00% | 1,373,440 |
24-12-05 | 21.46 $ | -4.71% | 1,878,136 |
24-12-04 | 22.52 $ | -2.09% | 1,607,111 |
24-12-03 | 23.00 $ | -3.40% | 802,890 |
24-12-02 | 23.81 $ | -0.13% | 1,001,440 |
Delayed Quote Nasdaq, December 06, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- SGRY Stock